SEC FORM
5
SEC Form 5
| FORM 5 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0362 |
| Estimated average burden |
| hours per response: |
1.0 |
|
|
 |
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b). |
|
Form 3 Holdings Reported. |
|
Form 4 Transactions Reported. |
1. Name and Address of Reporting Person*
| C/O SIANA CARR O'CONNOR & LYNAM, |
| 1500 EAST LANCASTER AVENUE |
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
AMKOR TECHNOLOGY, INC.
[ AMKR ]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
|
10% Owner |
|
Officer (give title below) |
X |
Other (specify below) |
| Exhibit 99.1 |
|
3. Statement for Issuer's Fiscal Year Ended
(Month/Day/Year)
12/31/2017
|
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
| X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
|---|
| 1. Title of Security (Instr.
3)
|
2. Transaction Date
(Month/Day/Year) |
2A. Deemed Execution Date, if any
(Month/Day/Year) |
3. Transaction Code (Instr.
8)
|
4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)
|
5.
Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr.
3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
7. Nature of Indirect Beneficial Ownership (Instr.
4)
|
| Amount |
(A) or (D) |
Price |
| Common Stock |
03/02/2017 |
|
J
|
1,687,829 |
D |
$10.21
|
9,967,064 |
D |
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|---|
| 1. Title of Derivative Security (Instr.
3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date
(Month/Day/Year) |
3A. Deemed Execution Date, if any
(Month/Day/Year) |
4. Transaction Code (Instr.
8)
|
5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
|
6. Date Exercisable and Expiration Date
(Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)
|
8. Price of Derivative Security (Instr.
5)
|
9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)
|
10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
11. Nature of Indirect Beneficial Ownership (Instr.
4)
|
| (A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
| Explanation of Responses: |
|
| Remarks: |
|
|
Christie B. Tillapaugh, as Attorney in Fact |
02/14/2018 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
LIMITED POWER OF ATTORNEY
Know all by these presents, that each of the undersigned hereby makes,
constitutes and appoints Jerry Allison, Gil C. Tily, Christie B. Tillapaugh and
Richard D. Rosen (any of whom may act individually) as the true and lawful
attorney-in-fact of each of the undersigned, with full power and authority as
hereinafter described on behalf of and in the name, place and stead of each of
the undersigned to:
(1) prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5
(including any amendments thereto) and any Schedule 13D (including any
amendments thereto) with respect to the securities of Amkor Technology, Inc., a
Delaware corporation (the "Company"), with the United States Securities and
Exchange Commission, any national securities exchanges and the Company, as
considered necessary or advisable under Section 16(a) of the Securities Exchange
Act of 1934 and the rules and regulations promulgated thereunder, as amended
from time to time (the "Exchange Act"), including obtaining any filing codes or
reissuance of existing filing codes, if necessary, in connection therewith;
(2) seek or obtain, as the representative of each of the undersigned and
on behalf of each of the undersigned, information on transactions in the
Company's securities from any third party, including brokers, employee benefit
plan administrators and trustees, and the undersigned hereby authorizes any such
person to release any such information to such attorney-in-fact and approves and
ratifies any such release of information; and
(3) perform any and all other acts which in the discretion of such
attorney-in-fact are necessary or desirable for and on behalf of the undersigned
in connection with the foregoing.
Each of the undersigned acknowledges that:
(1) this Power of Attorney authorizes, but does not require, such
attorney-in-fact to act in his or her discretion on information provided to such
attorney-in-fact without independent verification of such information;
(2) any documents prepared and/or executed by such attorney-in-fact on
behalf of any of the undersigned pursuant to this Power of Attorney will be in
such form and will contain such information and disclosure as such attorney-in-
fact, in his or her discretion, deems necessary or desirable;
(3) neither the Company nor such attorney-in-fact assumes (i) any
liability for any of the undersigneds' responsibility to comply with the
requirements of the Exchange Act, (ii) any liability of any of the undersigned
for any failure to comply with such requirements, or (iii) any obligation or
liability of any of the undersigned for profit disgorgement under Section 16(b)
of the Exchange Act;
(4) this Power of Attorney does not relieve any of the undersigned from
responsibility for compliance with any of the undersigneds' obligations under
the Exchange Act, including without limitation the reporting requirements under
Section 16 of the Exchange Act; and
(5) this Power of Attorney supersedes and replaces any prior power of
attorney executed by any of the undersigned for any of the purposes set forth
herein.
Although this Power of Attorney supersedes and replaces any prior
power of attorney executed by any of the undersigned for any of the purposes set
forth herein, each of the undersigned hereby ratifies and approves of any
actions taken pursuant to any prior power of attorney for any of the purposes
set forth herein, including without limitation the granting thereof by any of
the undersigned on his, her or its behalf. Each of the undersigned hereby gives
and grants the foregoing attorney-in-fact full power and authority to do and
perform all and every act and thing whatsoever requisite, necessary or
appropriate to be done in andabout the foregoing matters as fully to all intents
and purposes as the undersigned might or could do ifpresent, hereby ratifying
all that such attorney-in-fact shall lawfully do or cause to be done of, for and
on behalf of any of the undersigned by virtue of this Power of Attorney.
This Power of Attorney may be executed in several counterparts, each
of which shall be deemed an original but all of which shall constitute one and
the same instrument.
This Power of Attorney shall remain in full force and effect until
revoked by any of the undersigned in a signed writing delivered to the attorney-
in-fact.
THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK
Signature Page to Limited Power of Attorney
IN WITNESS WHEREOF, the undersigned have each caused this Power of Attorney to
be executed as of the 19th day of December, 2012.
List of entities covered by this Power of Attorney:
* John T. Kim 2012 Irrevocable Trust U/A dated 12/11/12
* John T. Kim 2012 Generation-Skipping Trust U/A dated 12/11/12
JOHN T. KIM 2012 IRREVOCABLE
TRUST U/A dated 12/11/12
By: /s/ Signature on File
---------------------
John T. Kim, Trustee
By: /s/ Signature on File
---------------------
James J. Kim, Trustee
JOHN T. KIM 2012 GENERATION-
SKIPPING TRUST U/A dated 12/11/12
By/s/ Signature on File
---------------------
John T. Kim, Trustee
By: /s/ Signature on File
---------------------
James J. Kim, Trustee
Exhibit 99.1
A Schedule 13D was filed by James J. Kim and those members of the reporting
group who then constituted the group on November 28, 2005, as amended by
Amendment No. 1 filed with the Securities and Exchange Commission (the
"Commission") on April 4, 2008, Amendment No. 2 filed with the Commission on
March 19, 2009, Amendment No. 3 filed with the Commission on April 16, 2009,
Amendment No. 4 filed with the Commission on February 5, 2010, Amendment No. 5
filed with the Commission on March 28, 2011, Amendment No. 6 filed with the
Commission on November 17, 2011, Amendment No. 7 filed with the Commission on
March 29, 2013, Amendment No. 8 filed with the Commission on March 28, 2014,
Amendment No. 9 filed with the Commission on March 30, 2015, Amendment No. 10
filed with the Commission on March 30, 2016, and Amendment No. 11 filed with the
Commission on January 20, 2017, (as further amended from time to time, the
"Schedule 13D"). Those individuals and entities listed in the Schedule 13D,
including the filer of this Form 5, may be deemed to be members of a group (the
"Group") who each exercise voting or investment power with respect to shares of
Amkor Technology, Inc.'s (the "Issuer") Common Stock in concert with other
members of the Group. The Group may be deemed to beneficially own more than 10%
of the outstanding voting securities of the Issuer. The reporting person states
that the filing of this Form 5 Report shall not be deemed an admission that the
reporting person is the beneficial owner of the reported securities owned by the
other members of the Group, for the purpose of Section 16 of the Securities
Exchange Act of 1934, as amended, or for any other purpose.
